Human heart mapped cell by cell
On Sept. 24, 2020, a team of scientists announced they had created the first atlas of human heart…
FDA took actions to help lower US prescription drug prices
On Sept. 24, 2020, the U.S. Department of Health and Human Services and the U.S. Food and Drug…
Fourth large-scale COVID-19 vaccine trial began in the United States
On Sept. 23, 2020, a fourth Phase 3 clinical trial evaluating an investigational vaccine for coronavirus disease 2019…
Countries urged to take stronger action to stop spread of harmful COVID-19 pandemic information
On Sept. 23, 2020, the WHO with the UN, specialised agencies and partners called on countries to develop…
Sinovacï¾’s Coronavacï¾™, SARS-CoV-2 vaccine, inactivated, announced approval for phase I/II clinical trial in adolescents and children
On Sept. 23, 2020, Sinovac Biotech announced that the inactivated COVID-19 vaccine candidate developed by Sinovac Life Sciences,…
FDA authorized first point-of-care antibody test for COVID-19
On Sept. 23, 2020, the FDA issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care…
US Cruise ship no sail order extended through October 31, 2020
On Sept. 23, 2020, the CDC announced the extension of a No Sail Order for cruise ships through…
CDC provided $200 million to jurisdictions for COVID-19 vaccine preparedness
On Sept. 23, 2020, the CDC awarded $200 million to 64 jurisdictions through the existing Immunizations and Vaccines…
Humanigen announced Thermo Fisher partnership to expand manufacturing for COVID-19 therapeutic candidate Lenzilumab
On Sept. 23, 2020, Humanigen announced a strategic collaboration with Thermo Fisher Scientific to expand the manufacturing capacity…
Johnson & Johnson initiated pivotal global phase 3 clinical trial of Janssen’s COVID-19 vaccine candidate
On Sept. 23, 2020, Johnson & Johnson announced the launch of its large-scale, pivotal, multi-country Phase 3 trial…
NIH expanded clinical trials to test convalescent plasma against COVID-19
On Sept. 22, 2020, the NIH annunced that two randomized, placebo-controlled clinical trials expanded enrollment to further evaluate…
FDA launched the Digital Health Center of Excellence
On Sept. 22, 2020, the FDA announced it had launched the Digital Health Center of Excellence within the…
Sanofi and GSK signed agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine
On Sept. 22, 2020, Sanofi and GSK announced they had signed agreements with the Government of Canada for…
Serum Institute initiated manufacturing of Codagenix’s intranasal live-attenuated COVID-19 vaccine candidate
On Sept. 22, 2020, Codagenix announced that the Serum Institute of India has begun manufacturing CDX-005, the company’s…
ViralClear expanded ongoing phase 2 trial size for oral anti-viral for treatment of COVID-19
On Sept. 22, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced that the size of the ongoing…
Study found that childrenï¾’s immune response protected against COVID-19
On Sept. 21, 2020, a study comparing the immune responses of adults and children with COVID-19 detected key…
XBiotech to develop human antibody combination as candidate treatment for influenza-COVID-19 co-infection
On Sept. 21, 2020, XBiotech announced it was developing a new breakthrough candidate therapy it calls FLUVIDï¾™ for…
Roche launched new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccines
On Sept. 18, 2020, Roche announced the launch of its Elecsysï¾® Anti-SARS-CoV-2 S antibody test for markets accepting…
Sanofi and GSK confirmed agreement with European Union to supply up to 300 million doses of adjuvanted COVID-19 vaccine
On Sept. 18, 2020, Sanofi and GSK finalised and signed an advanced purchase agreement with the European Commission…
UConn researchers validate clinical feasibility for COVID-19 testing at point of care
On Sept. 18, 2020, Uconn researchers, in a paper published in Nature Communications, validated the clinical feasibility of…
Rigel announced NIH/NHLBI-sponsored trial of fostamatinib in hospitalized COVID-19 patients in collaboration with Inova
On Sept. 17, 2020, Rigel Pharma announced the start of a multicenter, Phase 2 trial to evaluate the…
Rapid test for COVID-19 showed improved sensitivity
On Sept. 17, 2020, researchers announced a CRISPR-based test developed at MIT and the Broad Institute that can…
3CL protease inhibitor NLC-001 added to COVID-19-focused joint venture between Todos Medical and NLC Pharma
On Sept. 17, 2020, Todos Medical announced that NLC Pharma had added the dietary supplement NLC-001 to its…
BioNTech acquired GMP manufacturing site to expand COVID-19 vaccine production
On Sept. 17, 2020, BioNTech announced an agreement with Novartis to acquire their GMP certified manufacturing facility in…
NIH funded community engagement research efforts in areas hardest hit by COVID-19
On Sept. 16, 2020, the NIH announced a $12 million award for outreach and engagement efforts in ethnic…
Lilly announced proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting
On Sept. 16, 2020, Eli Lilly announced proof of concept data from an interim analysis of the BLAZE-1…
NanoViricides nominated a novel candidate for advancing Into clinical trials for treatment of COVID-19
On Sept. 16, 2020, NanoViricides announced that it had nominated a clinical drug candidate for the treatment of…
AIM ImmunoTech announced start of recruitment in clinical trial incorporating Ampligen in treatment of cancer patients with COVID-19
On Sept. 16, 2020, AIM ImmunoTech announced that recruitment had begun in Roswell Park Comprehensive Cancer Center’s Phase…
Laboratory testing of Brilacidin for COVID-19 in combination with remdesivir reduces viral load by nearly 100 percent
On Sept. 15, 2020, Innovation Pharma reported additional data from a U.S. Regional Biocontainment Laboratory (RBL) collected during…
New anti-infective drugs had a 14% speed advantage vs other drugs from 2000-2019
On Sept. 15, 2020, the Tufts Center for the Study of Drug Development reported that new anti-infective drugs…